default author photo

Tyra Jean

Government of New South Wales - Serology and Virology Division (SAViD)

SCHOLARLY PAPERS

2

DOWNLOADS

227

TOTAL CITATIONS

4

Scholarly Papers (2)

1.

SARS-CoV-2 Omicron BA.5: Evolving Tropism and Evasion of Potent Humoral Responses and Resistance to Clinical Immunotherapeutics Relative to Viral Variants of Concern

Number of pages: 14 Posted: 11 Jul 2022
University of New South Wales (UNSW) - Kirby Institute, University of New South Wales (UNSW) - Kirby Institute, University of New South Wales (UNSW) - Kirby Institute, University of New South Wales (UNSW) - Kirby Institute, Government of New South Wales - Virology Research Laboratory, University of New South Wales (UNSW) - Kirby Institute, Royal Melbourne Institute of Technology (RMIT University) - School of Health and Biomedical Sciences, Royal Melbourne Institute of Technology (RMIT University) - School of Health and Biomedical Sciences, CSL Behring AG - Department of Bioanalytical Sciences, CSL Behring AG - Department of Bioanalytical Sciences, CSL Behring AG - Department of Bioanalytical Sciences, Government of New South Wales - Serology and Virology Division (SAViD), Government of New South Wales - Virology Research Laboratory, University of New South Wales (UNSW) - Kirby Institute, University of New South Wales (UNSW) - Kirby Institute, St. Vincent's Hospital, Royal Melbourne Institute of Technology (RMIT University) - School of Health and Biomedical Sciences, St. Vincent's Hospital - Molecular Diagnostic Medicine Laboratory, Garvan Institute of Medical Research, University of New South Wales (UNSW) - Kirby Institute, Government of New South Wales - Virology Research Laboratory, University of New South Wales (UNSW) - Kirby Institute and University of New South Wales (UNSW) - Kirby Institute
Downloads 137 (534,155)
Citation 4

Abstract:

Loading...

SARS CoV2 Variants, immunotherapeutics, ACE2, TMPRSS2, Omicron

2.

Emergence and Antibody Evasion of BQ and BA.2.75 SARS-CoV-2 Sublineages in the Face of Maturing Antibody Breadth at the Population Level

Number of pages: 19 Posted: 21 Dec 2022
University of New South Wales (UNSW) - Kirby Institute, University of New South Wales (UNSW) - Kirby Institute, Government of New South Wales - Serology and Virology Division (SAViD), University of Newcastle - Hunter Medical Research Institute, University of New South Wales (UNSW) - Kirby Institute, University of New South Wales (UNSW) - Kirby Institute, University of New South Wales (UNSW) - Kirby Institute, The University of Sydney - Sydney Institute for Infectious Diseases, University of New South Wales (UNSW) - Kirby Institute, Government of New South Wales - Serology and Virology Division (SAViD), Government of New South Wales - Serology and Virology Division (SAViD), Government of New South Wales - Serology and Virology Division (SAViD), Government of New South Wales - Virology Research Laboratory, CSL Behring AG - Department of Bioanalytical Sciences, CSL Behring AG - Department of Bioanalytical Sciences, CSL Behring AG, CSL Behring AG, CSL Behring AG, Government of New South Wales - Virology Research Laboratory, CSL Behring AG - Department of Bioanalytical Sciences, Government of New South Wales - Serology and Virology Division (SAViD), Government of New South Wales - Virology Research Laboratory, The University of Sydney - Westmead Hospital, The University of Sydney - Westmead Hospital, The University of Sydney - Westmead Hospital, The University of Sydney - Westmead Hospital, The University of Sydney - Royal Prince Alfred Hospital, The University of Sydney - Royal Prince Alfred Hospital, The University of Sydney - Royal Prince Alfred Hospital, The University of Sydney - Westmead Institute for Medical Research, The University of Sydney - Royal Prince Alfred Hospital, The University of Sydney - Westmead Institute for Medical Research, University of New South Wales (UNSW) - Kirby Institute, University of New South Wales (UNSW) - Kirby Institute, The University of Sydney, Garvan Institute of Medical Research, University of Newcastle (Australia) - Viral Immunology and Respiratory Disease Group, St. Vincent's Hospital, University of New South Wales (UNSW) - Kirby Institute, St. Vincent's Hospital - Molecular Diagnostic Medicine Laboratory, Government of New South Wales - Virology Research Laboratory, The University of Sydney - School of Medical Sciences, The University of Sydney - Westmead Institute for Medical Research, University of New South Wales (UNSW) - Kirby Institute, University of New South Wales (UNSW) - Kirby Institute and University of New South Wales (UNSW) - Kirby Institute
Downloads 90 (742,061)

Abstract:

Loading...

SARS-CoV-2Covid-19Neutralising antibodiesSotrovimabEvusheld